117 related articles for article (PubMed ID: 38848971)
1. Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling.
Erdenebileg S; Kim M; Nam Y; Cha KH; Le TT; Jung SH; Nho CW
J Ethnopharmacol; 2024 Jun; 333():118415. PubMed ID: 38848971
[TBL] [Abstract][Full Text] [Related]
2.
Nam Y; Kim M; Erdenebileg S; Cha KH; Ryu DH; Kim HY; Lee SH; Jung JH; Nho CW
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686810
[TBL] [Abstract][Full Text] [Related]
3. Terminalia bellirica ethanol extract ameliorates nonalcoholic fatty liver disease in mice by amending the intestinal microbiota and faecal metabolites.
Zhang B; Luo X; Han C; Liu J; Zhang L; Qi J; Gu J; Tan R; Gong P
J Ethnopharmacol; 2023 Apr; 305():116082. PubMed ID: 36581163
[TBL] [Abstract][Full Text] [Related]
4. Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis.
Yao Q; Li S; Li X; Wang F; Tu C
Front Med (Lausanne); 2020; 7():71. PubMed ID: 32195263
[TBL] [Abstract][Full Text] [Related]
5. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet.
Dungubat E; Watabe S; Togashi-Kumagai A; Watanabe M; Kobayashi Y; Harada N; Yamaji R; Fukusato T; Lodon G; Sevjid B; Takahashi Y
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33353230
[TBL] [Abstract][Full Text] [Related]
6. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
[TBL] [Abstract][Full Text] [Related]
7. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
9. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatic integrin αvβ3 expression in non-alcoholic steatohepatitis (NASH) model mouse by
Rokugawa T; Konishi H; Ito M; Iimori H; Nagai R; Shimosegawa E; Hatazawa J; Abe K
EJNMMI Res; 2018 May; 8(1):40. PubMed ID: 29855729
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
[TBL] [Abstract][Full Text] [Related]
12. Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis.
Kruger AJ; Fuchs BC; Masia R; Holmes JA; Salloum S; Sojoodi M; Ferreira DS; Rutledge SM; Caravan P; Alatrakchi N; Vig P; Lefebvre E; Chung RT
Hepatol Commun; 2018 May; 2(5):529-545. PubMed ID: 29761169
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse.
Takano K; Kaneda M; Aoki Y; Fujita N; Chiba S; Michihara S; Han LK; Takahashi R
J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120
[TBL] [Abstract][Full Text] [Related]
14. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
[TBL] [Abstract][Full Text] [Related]
15. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver.
Liao J; Cao Y; Zhao J; Yu B; Wang Y; Li W; Li H; Lv S; Wen W; Cui H; Chen Y
Phytomedicine; 2023 Sep; 118():154937. PubMed ID: 37393831
[TBL] [Abstract][Full Text] [Related]
16. A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells.
Kasahara N; Imi Y; Amano R; Shinohara M; Okada K; Hosokawa Y; Imamori M; Tomimoto C; Kunisawa J; Kishino S; Ogawa J; Ogawa W; Hosooka T
Sci Rep; 2023 Nov; 13(1):18983. PubMed ID: 37923895
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
[TBL] [Abstract][Full Text] [Related]
18. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
19. Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis.
Shen B; Wang J; Guo Y; Gu T; Shen Z; Zhou C; Li B; Xu X; Li F; Zhang Q; Cai X; Dong H; Lu L
Front Microbiol; 2021; 12():756299. PubMed ID: 34795650
[No Abstract] [Full Text] [Related]
20. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.
Xiao J; Xiang H; Xiang H; Sun Z; Xu J; Ren H; Hu P; Peng M
Eur J Pharmacol; 2023 Dec; 960():176113. PubMed ID: 37838102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
